Stellar Pharmaceuticals Inc. (SLX.V) Enters Into a Partnership With Pfizer Canada Inc. to Promote Gelfoam(R) in Canada
8/23/2012 8:00:35 AM
More...
|
Health Canada Approves Stellar Pharmaceuticals Inc. (SLX.V)'s CAMBIA(R) for the Treatment of Acute Migraine
3/16/2012 8:35:20 AM
More...
|
Apricus Biosciences (APRI), Stellar Pharmaceuticals Inc. (SLX.V) Sign MycoVa License Agreement in Canada
1/3/2012 7:48:00 AM
More...
|
Stellar Pharmaceuticals Inc. (SLX.V) Receives European Approval for NeoVisc(R) Single Dose
9/13/2011 7:12:44 AM
More...
|
Stellar Pharmaceuticals Inc. (SLX.V) and Watson Pharmaceuticals, Inc. (WPI) Terminate Uracyst(R) Supply and Licensing Agreements
4/13/2011 6:58:09 AM
More...
|
Stellar Pharmaceuticals Inc. (SLX.V) Announces Retirement of Peter Riehl as CEO, President and Director
1/18/2011 6:45:23 AM
More...
|
Stellar Pharmaceuticals Inc. (SLX.V) Annouces the Approval of Uracyst(R) by the KFDA in South Korea
1/6/2011 9:32:00 AM
More...
|
Stellar Pharmaceuticals Inc. (SLX.V) Provides Further Update on the Watson Pharmaceuticals, Inc. (WPI)'s Ur008 Pilot Study of Uracyst(R)
11/16/2010 9:30:39 AM
More...
|
Watson Pharmaceuticals, Inc. (WPI) Backs off from U.S. Plan for Stellar Pharmaceuticals Inc. (SLX.V)'s Uracyst Bladder Treatment After Study Does Not Meet Primary Endpoints
11/11/2010 6:58:02 AM
More...
|
Stellar Pharmaceuticals Inc. (SLX.V) Reports Third Quarter 2010 Financial Results
11/9/2010 9:17:50 AM
More...
|
|